Testing effectiveness (Phase 2)Study completedNCT00453895What this trial is testingSunitinib in Refractory Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma University of Wuerzburg 39
Not applicableUnknownNCT03221335What this trial is testingEUS-guided RFA for Solid Abdominal NeoplasmsWho this might be right forDigestive System Neoplasms Chinese University of Hong Kong 30
Early research (Phase 1)Looking for participantsNCT06041516What this trial is testingAntibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and CarcinomasWho this might be right forNeuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more National Cancer Institute (NCI) 70
Not applicableLooking for participantsNCT07072143What this trial is testingAn International Study on Pediatric Patients With Rare Tumors.Who this might be right forParaganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more Azienda Ospedaliera di Padova 6,250
Very early researchStudy completedNCT05361083What this trial is testingFirst-in-human Evaluation of [18F]CETOWho this might be right forPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Nodular HyperplasiaAdrenal Cushing Syndrome+2 more Uppsala University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05036434What this trial is testingPhase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical CarcinomaWho this might be right forAdrenocortical Carcinoma National Cancer Center, Korea 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT00848016What this trial is testingGossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00003453What this trial is testingAntineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerWho this might be right forStage IV Adrenocortical Carcinoma Burzynski Research Institute 6
Testing effectiveness (Phase 2)Study completedNCT00324012What this trial is testingTrial With Taxotere and Cisplatin in Non-operable Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Rigshospitalet, Denmark 19
Not applicableStudy completedNCT02592356What this trial is testingEffect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more M.D. Anderson Cancer Center 23
Not applicableLooking for participantsNCT00453674What this trial is testingGerman Adrenocortical Carcinoma RegistryWho this might be right forAdrenocortical Carcinoma University of Wuerzburg 1,000
Testing effectiveness (Phase 2)Study completedNCT01262235What this trial is testingA Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsWho this might be right forCancerNeuroendocrine TumorsNET+2 more Arbutus Biopharma Corporation 68
Testing effectiveness (Phase 2)UnknownNCT00786110What this trial is testingSorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsWho this might be right forAdrenocortical Carcinoma University of Turin, Italy 30
Large-scale testing (Phase 3)Study completedNCT00924989What this trial is testingOSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Study completedNCT00001339What this trial is testingCombination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical ResectionWho this might be right forAdrenal Cortical Carcinoma National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT01898715What this trial is testingPhase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical CarcinomaAdrenal CancerACC Millendo Therapeutics, Inc. 63
Testing effectiveness (Phase 2)Study completedNCT00831844What this trial is testingCixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forAdult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more National Cancer Institute (NCI) 116